Clinical trials: Osteogenesis Imperfecta
- Condition Osteogenesis Imperfecta
- Funder type Industry (pharma, biotech, devices)
- Accepts healthy volunteers yes
Osteogenesis Imperfecta
A First-in-Human Study Evaluating AGA2115 in Adult Healthy Volunteers
To understand if AGA2115 is safe and well tolerated in healthy adult volunteers.
- Trial name
- NCT06086613
- Testing
- AGA2115
- Where
- United States
- Volunteers
- 72 people, healthy volunteers welcome
- Sponsor
- Angitia Incorporated Limited